Loading clinical trials...
Loading clinical trials...
An Open Label, Single Center, Pilot Study to Evaluate the Safety and Effectiveness of OCL 503 in Prostate Artery Embolization for the Treatment of Men With Benign Prostatic Hypertrophy
Conditions
Interventions
Prostate artery embolization.
Locations
1
Canada
University of Alberta Hospital
Edmonton, Alberta, Canada
Start Date
September 1, 2015
Primary Completion Date
May 1, 2018
Completion Date
May 1, 2018
Last Updated
August 8, 2018
NCT05574244
NCT03297281
NCT07016620
NCT07377929
NCT06312722
NCT06817733
Lead Sponsor
IMBiotechnologies Ltd.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions